Medical Device Cybersecurity News: Recent Highlights, Week of Monday, September 7, 2026

While the last few days have been relatively quiet for new regulatory filings, the past 90 days have seen significant shifts in how the industry manages legacy infrastructure and postmarket security. Manufacturers are currently transitioning away from long-standing support cycles while bracing for more stringent review of their postmarket maintenance files.

In this brief

• Legacy Fleet Management: RHEL 7 ELS Conclusion
• What to do this week
• How Blue Goat Cyber Helps
• FAQ

Why This Matters

For device manufacturers, the end of a major operating system support cycle is not just a technical hurdle but a regulatory compliance risk. Failure to document how a device remains secure after its underlying OS stops receiving patches can lead to delays in subsequent submissions or findings during postmarket inspections.

Legacy Fleet Management: RHEL 7 ELS Conclusion

## What to do this week * Identify every device model in your current catalog or service fleet that utilizes RHEL 7. * Draft a formal internal memo outlining the specific compensating controls used to protect these devices in the absence of OS security patches. * Schedule a review meeting with your regulatory affairs team to ensure the postmarket file for each affected device is updated to reflect the RHEL 7 ELS status.

How Blue Goat Cyber Helps

Blue Goat Cyber provides specialized guidance to help manufacturers manage legacy system security and FDA documentation. Our team assists in developing the necessary documentation and technical controls to maintain compliance throughout the device lifecycle. You can learn more about our approach at Blue Goat Cyber.

FAQ

Do devices using RHEL 7 need an immediate recall?

Where can I find a list of all regulatory changes for this quarter?

How do I contact Blue Goat Cyber for a review of my postmarket files?

Get the next issue

Subscribe to stay updated on the latest regulatory changes at Goat's Weekly.